Nivolumab 40 Mg Injection

Nivolumab 40 Mg Injection Specification

Grade
Pharma

Appearance
Liquid

Storage
Dry Place

Usage
Hospital

Dosage
100 mg

Nivolumab 40 Mg Injection Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Nivolumab 40 Mg Injection

Nivolumab 40 Mg Injection is a medication that belongs to a class of drugs known as immune checkpoint inhibitors. Thos is indicated for the treatment of various types of cancer, including melanoma, non-small cell lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, and certain types of gastric cancer, esophageal cancer, and cervical cancer. It works by targeting and blocking a protein called programmed cell death protein 1 (PD-1) on certain immune cells called T cells. Nivolumab 40 Mg Injection is effective in the treatment of several types of cancer, often providing durable responses and prolonged survival in some patients.

Specification

Brand name	Nivolumab 40mg injection
origin	made in India
Therapy	ANTI-NEOPLASTIC
uses	lung cancer, skin cancer, small cell lung cancer kidney cancer, hodgkins disease
Strength	100 mg

Targeted Cancer Therapy Solution

Nivolumab 40 mg Injection offers a reliable immunotherapy option for cancer patients, working by targeting immune checkpoints to help the body recognize and attack malignancies. Its liquid formulation ensures precise dosing and easy administration under medical supervision.

Pharmaceutical Quality Guaranteed

This injection adheres to the highest pharma grade standards for quality and efficacy. Sourced and produced in India for export and wholesale, each batch meets strict regulatory requirements to ensure safe patient outcomes and dependable supply chains.

FAQ's of Nivolumab 40 Mg Injection:

Q: How should Nivolumab 40 mg Injection be stored for optimal efficacy?

A: Nivolumab 40 mg Injection should be stored in a dry place as per the manufacturer's guidelines to maintain its pharmaceutical quality and prevent degradation.

Q: What is the recommended usage of Nivolumab 40 mg Injection in hospitals?

A: Nivolumab is typically used under the supervision of qualified healthcare professionals within hospital settings to treat specific cancers, following tailored dosage regimens.

Q: When is Nivolumab 40 mg Injection administered to patients?

A: Patients receive Nivolumab 40 mg Injection according to individualized treatment schedules determined by their oncologist, often as part of a larger immunotherapy strategy.

Q: Where is Nivolumab 40 mg Injection manufactured and available for export?

A: This medication is manufactured and distributed from India, available to exporters and wholesalers for supplying international hospital markets.

Q: What are the benefits of using Nivolumab 40 mg Injection over conventional therapies?

A: Nivolumab enhances the body's immune response against cancer cells, potentially offering improved outcomes and reduced side effects compared to traditional chemotherapy in select cancer types.

Q: How is Nivolumab 40 mg Injection prepared and administered?

A: The injection is provided as a liquid solution and should be prepared and administered intravenously by trained hospital personnel to ensure accurate dosage and patient safety.